Clinical Trial: Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves
Brief Summary: Validate the use of fetal urine peptidome-analysis for the stratification of fetuses with Posterior Urethral Valve for post-natal renal function.
Detailed Summary:
The ANTENATAL project requires the use of fetal urine as well as post-natal urine, post-natal serum and, possibly, amniotic liquid. We will take an additional tube during the takings collected for routine management of the disease.
The analysis of samples will be carried out in Toulouse at the Institute of Metabolic and Cardiovascular Diseases or with fee-for-service suppliers.
Sponsor: University Hospital, Toulouse
Current Primary Outcome: Renal/patient survival at 2 years post-natally. [ Time Frame: Year 2 ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Renal function of the survivors at day 4 and 6 and 12 month post-natally. [ Time Frame: Year 1 ]
Original Secondary Outcome: Same as current
Information By: University Hospital, Toulouse
Dates:
Date Received: March 10, 2017
Date Started: May 1, 2017
Date Completion: August 31, 2022
Last Updated: April 28, 2017
Last Verified: April 2017